Astarte, 2020 Cohort
Astarte Medical, a clinical intelligence company, announced it signed a contract with UVA Children’s to implement its NICUtrition software platform to analyze and understand feeding metrics and milestones and the corresponding growth outcomes for preterm infants in the neonatal ICU (NICU).
EchoIQ, 2022 Cohort
EchoIQ has moved closer to the commercial introduction of its cloud-based solution for the retrospective and real-time identification of guideline-defined severe aortic stenosis during the period. Steady progress was also made toward FDA certification. Read more here.
EchoIQ demonstrated positive results in two clinical trials and positioned itself to see initial commercial uptake of the cloud-based product later this year. Read more here.
Genetesis, 2021 Cohort
Genetesis, Inc., the leader in biomagnetic cardiac imaging solutions, announced the appointment of three new members to the executive leadership team who will oversee and execute key aspects of commercialization and clinical research for its flagship solution, CardioFlux. Read more here.
iCardio.ai, 2022 Cohort
Techstars announced that iCardio.ai has been selected for participation in their 2023 accelerator program. Read more here.
iCardio shared that their scientific research was accepted for publication in the Journal of the American Society of Echocardiography (JASE). Read more here.
Lapovations, 2018 Cohort
Fayetteville medical device company Lapovations closed an oversubscribed Series A funding round led by investments from multiple angel investors and groups. Read more here.
Lapovations has attracted more than $3.5 million in dilutive and non-dilutive investment and has 50 independent sales representatives operating in 18 states. Read more here.
Mediwhale, 2022 Cohort
Mediwhale, the AI-empowered health diagnostics company that uses retina scans to diagnose future cardiac and kidney disorder risk quickly and easily, has been accepted into the 2023 cohort of StartX. Read more here.
Mediwhale was selected for the MedTech Accelerator. Read more here.
MediWhale received nice coverage on CNBC: A 26-year-old founded a medical startup — the same year he lost almost half his vision. Read more here.
Movn Health, 2021 Cohort
Movn Health, a leading virtual cardiac rehabilitation and prevention provider, announced that it is launching single sign-on authentication for its entire software platform. Read more here.
Movn Health, a virtual cardiac rehabilitation and prevention provider, announced that it has successfully passed the American Institute of Certified Public Accountants (AICPA) Service Organization Control (SOC) 2 Examination and has received the SOC 2 Type 2 report. This affirms the company’s strong data-security protocols. Read more here.
Movn Health was selected as a 2022 UCSF Rosenman ADAPT Program (ADAPT) awardee. ADAPT accelerates developing, scaling, and adopting novel technologies that tackle the most pressing healthcare disparities by pairing early-stage companies with large industry players. Read more here.
OMNY, 2019 Cohort
OMNY, one of our 2019 cohort companies, has partnered with Atropos Health, a leader in generating personalized, real-world evidence at the point and pace of care. Read more here.
Sonivie, 2021 Cohort
Sonivie, a medical device company developing a proprietary solution to treat hypertension, announced the completion of a $60 million series C round financing. The financing was led by Andera Partners, with participation from Supernova Invest and Omega Funds. Read more here.
Zeto, 2020 Cohort
Zeto, Inc., an innovative EEG brain monitoring company, announced the integration of FDA-cleared seizure detection and trending algorithms developed by Encevis, into its EEG platform. Read more here.